{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T03:07:23Z","timestamp":1785467243913,"version":"3.56.0"},"reference-count":66,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","strokejournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Stroke and Cerebrovascular Diseases"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.jstrokecerebrovasdis.2018.02.033","type":"journal-article","created":{"date-parts":[[2018,4,13]],"date-time":"2018-04-13T09:13:14Z","timestamp":1523610794000},"page":"1921-1929","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Which Ischemic Stroke Subtype Is Associated with Hyperhomocysteinemia?"],"prefix":"10.1016","volume":"27","author":[{"given":"Levent","family":"Gungor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"Polat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehlika Berra","family":"Ozberk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahattin","family":"Avci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4811-9321","authenticated-orcid":false,"given":"Ummet","family":"Abur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jstrokecerebrovasdis.2018.02.033_bib0010","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1258\/0004563001899915","article-title":"Total homocysteine measurement in clinical practice","volume":"37","author":"Rasmussen","year":"2000","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.02.033_bib0015","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1212\/WNL.59.4.529","article-title":"Homocysteine, MTHFR 677CT polymorphism, and risk of ischemic stroke. Results of a meta-analysis","volume":"59","author":"Kelly","year":"2002","journal-title":"Neurol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.02.033_bib0020","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1161\/01.ATV.18.1.133","article-title":"Hyperhomocysteinemia is associated with an increased risk of cardiovascular disease, especially in non-insulin-dependent diabetes mellitus: A population-based study","volume":"18","author":"Hoogeveen","year":"1998","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"Suppl 1","key":"10.1016\/j.jstrokecerebrovasdis.2018.02.033_bib0025","first-page":"18","article-title":"Hyperhomocysteinemia is a risk factor for venous and arterial thrombosis","volume":"101","author":"Makris","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.02.033_bib0030","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1056\/NEJM199707243370403","article-title":"Plasma homocysteine levels and mortality in patients with coronary artery disease","volume":"337","author":"Nygard","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.02.033_bib0035","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1056\/NEJM199104253241701","article-title":"Hyperhomocysteinemia: an independent risk factor for vascular disease","volume":"324","author":"Clarke","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.02.033_bib0040","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1161\/01.CIR.79.6.1180","article-title":"Prevalence of hyperhomocyst(e)inemia in patients with peripheral arterial occlusive disease","volume":"79","author":"Malinow","year":"1989","journal-title":"Circ"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.02.033_bib0045","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1055\/s-2007-996027","article-title":"Hyperhomocysteinemia and venous thrombosis","volume":"24","author":"Bos","year":"1998","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.02.033_bib0050","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1055\/s-0037-1615380","article-title":"Hyperhomocysteinemia and venous thrombosis: a meta-analysis","volume":"80","author":"Den Heijer","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.02.033_bib0055","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1001\/archinte.159.1.38","article-title":"Homocysteine and short-term risk of myocardial infarction and stroke in the elderly: the Rotterdam Study","volume":"159","author":"Bots","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.02.033_bib0060","doi-asserted-by":"crossref","first-page":"557","DOI":"10.3109\/10641963.2015.1026039","article-title":"Association between homocysteine and incidence of ischemic stroke in subjects with essential hypertension: a matched case-control study","volume":"37","author":"Wang","year":"2015","journal-title":"Clin Exp Hypertens"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.02.033_bib0065","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1179\/016164106X91834","article-title":"Serum level of homocysteine is correlated to carotid artery atherosclerosis in Chinese with ischemic stroke","volume":"28","author":"Wang","year":"2006","journal-title":"Neurol Res"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.02.033_bib0070","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s12031-015-0497-6","article-title":"Elevated serum homocysteine levels may contribute to the pathogenesis of cerebral infarction","volume":"56","author":"Fu","year":"2015","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.02.033_bib0075","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1161\/01.CIR.0000131942.77635.2D","article-title":"Serum total homocysteine concentrations and risk of stroke and its subtypes in Japanese","volume":"109","author":"Iso","year":"2004","journal-title":"Circ"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.02.033_bib0080","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.numecd.2014.05.011","article-title":"Homocysteine level and risk of different stroke types: a meta-analysis of prospective observational studies","volume":"24","author":"He","year":"2014","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.02.033_bib0085","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1017\/S0954422409990023","article-title":"Stroke: roles of B vitamins, homocysteine and antioxidants","volume":"22","author":"Sanchez-Moreno","year":"2009","journal-title":"Nutr Res Rev"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.02.033_bib0090","doi-asserted-by":"crossref","first-page":"495","DOI":"10.18388\/abp.2012_2083","article-title":"Homocysteine, heat shock proteins, genistein and vitamins in ischemic stroke: pathogenic and therapeutic implications","volume":"59","author":"Banecka-Majkutewicz","year":"2012","journal-title":"Acta Biochim Pol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.02.033_bib0095","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1161\/01.STR.0000142374.33919.92","article-title":"Homocysteine and the risk of ischemic stroke in a triethnic cohort: the Northern Manhattan Study","volume":"35","author":"Sacco","year":"2004","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.02.033_bib0100","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.clinbiochem.2004.02.006","article-title":"Various forms of homocysteine and oxidative status in the plasma of ischemic-stroke patients as compared to healthy controls","volume":"37","author":"Yang","year":"2004","journal-title":"Clin Biochem"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.02.033_bib0105","first-page":"1063","article-title":"Frequency of hyper-homocysteinaemia in ischaemic stroke patients of Karachi","volume":"64","author":"Sadiq","year":"2014","journal-title":"J Pak Med Assoc"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.02.033_bib0110","first-page":"4446","article-title":"Relationship between increase of serum homocysteine caused by smoking and oxidative damage in elderly patients with cardiovascular disease","volume":"8","author":"Chen","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.02.033_bib0115","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1161\/01.STR.31.5.1069","article-title":"Association between high homocysteine and ischemic stroke due to large- and small-artery disease but not other etiologic subtypes of ischemic stroke","volume":"31","author":"Eikelboom","year":"2000","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.02.033_bib0120","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1365-2362.1992.tb01829.x","article-title":"Hyperhomocysteinaemia in stroke: Prevalence, cause, and relationships to type of stroke and stroke risk factors","volume":"22","author":"Brattstrom","year":"1992","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.02.033_bib0125","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000047739","article-title":"Plasma homocysteine concentrations and the risk of subtypes of cerebral infarction. The Hisayama study","volume":"13","author":"Shimizu","year":"2002","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.02.033_bib0130","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s10072-005-0505-7","article-title":"Elevated plasma homocysteine in acute stroke was not associated with severity and outcome: stronger association with small artery disease","volume":"26","author":"Perini","year":"2005","journal-title":"Neurol Sci"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.02.033_bib0135","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1179\/016164109X12445616596445","article-title":"Homocysteine and ischemic stroke subtype: a relationship study in Chinese patients","volume":"32","author":"Ma","year":"2010","journal-title":"Neurol Res"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.02.033_bib0140","first-page":"233","article-title":"Evaluation of homocysteine level as a risk factor among patients with ischemic stroke and its subtypes","volume":"38","author":"Ashjazadeh","year":"2013","journal-title":"IJMS"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.02.033_bib0145","first-page":"541","article-title":"Experience from a multicentre stroke register: a preliminary report","volume":"54","author":"Hatano","year":"1976","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.02.033_bib0150","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1002\/ana.20617","article-title":"An evidence-based causative classification system for acute ischemic stroke","volume":"58","author":"Ay","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.02.033_bib0155","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1373\/clinchem.2008.115899","article-title":"National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: emerging biomarkers for primary prevention of cardiovascular disease","volume":"55","author":"Myers","year":"2009","journal-title":"Clin Chem"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.02.033_bib0160","first-page":"111","article-title":"Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis","volume":"56","author":"McCully","year":"1969","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.02.033_bib0165","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1161\/STROKEAHA.115.009111","article-title":"Homocysteine, ischemic stroke, and coronary heart disease in hypertensive patients. A population-based, prospective cohort study","volume":"46","author":"Han","year":"2015","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.02.033_bib0170","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.jstrokecerebrovasdis.2015.11.041","article-title":"Association between 5,10-ethylenetetrahydrofolate reductase C677T gene polymorphism and risk of ischemic stroke: a meta-analysis","volume":"25","author":"Song","year":"2016","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.02.033_bib0175","doi-asserted-by":"crossref","first-page":"e435","DOI":"10.1016\/j.jstrokecerebrovasdis.2013.04.031","article-title":"C-reactive protein and homocysteine predict long-term mortality in young ischemic stroke patients","volume":"22","author":"Naess","year":"2013","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.02.033_bib0180","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1161\/STROKEAHA.115.009136","article-title":"Elevated total homocysteine levels in acute ischemic stroke are associated with long-term mortality","volume":"46","author":"Shi","year":"2015","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.02.033_bib0185","article-title":"High homocysteine and blood pressure related to poor outcome of acute ischemia stroke in Chinese population","volume":"29","author":"Zhong","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.02.033_bib0190","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1161\/STROKEAHA.113.004099","article-title":"Homocysteine as a predictor of early neurological deterioration in acute ischemic stroke","volume":"45","author":"Kwon","year":"2014","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.02.033_bib0195","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.jstrokecerebrovasdis.2016.11.016","article-title":"Prognostic value of C-reactive protein and homocysteine in large-artery atherosclerotic stroke: a prospective observational study","volume":"26","author":"Ye","year":"2017","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.02.033_bib0200","doi-asserted-by":"crossref","first-page":"332e7","DOI":"10.1007\/s00415-005-0647-9","article-title":"Plasma homocysteine is a risk factor for recurrent vascular events in young patients with an ischaemic stroke or TIA","volume":"252","author":"Bos","year":"2005","journal-title":"J Neurol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.02.033_bib0205","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1159\/000047687","article-title":"Hyperhomocysteinemia is a risk factor of secondary vascular events in stroke patients","volume":"12","author":"Del Ser","year":"2001","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.02.033_bib0210","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1001\/jama.291.5.565","article-title":"Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction and death. The Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial","volume":"291","author":"Toole","year":"2007","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.jstrokecerebrovasdis.2018.02.033_bib0215","article-title":"Homocysteine-lowering interventions for preventing cardiovascular events","author":"Mart\u00ed-Carvajal","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.02.033_bib0220","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1177\/1747493015616512","article-title":"Effect of B-vitamins on stroke risk among individuals with vascular disease who are not on antiplatelets: a meta-analysis","volume":"11","author":"Park","year":"2016","journal-title":"Int J Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.02.033_bib0225","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1212\/WNL.0b013e3182a823cc","article-title":"Vitamin B supplementation, homocysteine levels, and the risk of cerebrovascular disease: a meta-analysis","volume":"81","author":"Ji","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.02.033_bib0230","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1093\/brain\/awh023","article-title":"Homocysteine as a risk factor for cerebral small vessel disease, acting via endothelial dysfunction","volume":"127","author":"Hassan","year":"2004","journal-title":"Brain"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.02.033_bib0235","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1161\/STROKEAHA.107.513416","article-title":"Homocysteine and its relationship to stroke subtypes in a UK black population: the South London Ethnicity and Stroke Study","volume":"39","author":"Khan","year":"2008","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.02.033_bib0240","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1161\/01.STR.0000021899.08659.C8","article-title":"Hyperhomocysteinemia and risk of ischemic stroke among young Asian adults","volume":"33","author":"Tan","year":"2002","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.02.033_bib0245","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1161\/STROKEAHA.112.676155","article-title":"Elevated homocysteine and carotid plaque area and densitometry in the Northern Manhattan study","volume":"44","author":"Alsulaimani","year":"2013","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.02.033_bib0250","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1161\/01.STR.0000016463.01398.D0","article-title":"Association of plasma homocysteine concentration with atherosclerotic carotid plaques and lacunar infarction","volume":"33","author":"Sasaki","year":"2002","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.02.033_bib0255","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1161\/hs1201.099650","article-title":"Cerebrovascular events in patients with significant stenosis of the carotid artery are associated with hyperhomocysteinemia and platelet antigen-1 (Leu33Pro) polymorphism","volume":"32","author":"Streifler","year":"2001","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.02.033_bib0260","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1161\/01.STR.29.12.2478","article-title":"Relation of plasma homocysteine to cerebral infarction and cerebral atherosclerosis","volume":"29","author":"Yoo","year":"1998","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.02.033_bib0265","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1159\/000360753","article-title":"Hyperhomocysteinemia and methylenetetrahydrofolate reductase polymorphism in cervical artery dissection: a meta-analysis","volume":"37","author":"Luo","year":"2014","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.02.033_bib0270","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1742-1241.2001.tb11030.x","article-title":"Aetiology and treatment of hyperhomocysteinaemia causing ischaemic stroke","volume":"55","author":"Sarkar","year":"2001","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.02.033_bib0275","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/00043798-199808000-00006","article-title":"Pathogenesis of vascular disease in hyperhomocysteinaemia","volume":"5","author":"Domagala","year":"1998","journal-title":"J Cardiovasc Risk"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.02.033_bib0280","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0049-3848(97)00266-1","article-title":"Homocysteinemia and endothelial damage after methionine load","volume":"88","author":"Hladovec","year":"1997","journal-title":"Thromb Res"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.02.033_bib0285","doi-asserted-by":"crossref","first-page":"35867","DOI":"10.1074\/jbc.M100747200","article-title":"Homocysteine induces programmed cell death in human vascular endothelial cells through activation of the unfolded protein response","volume":"276","author":"Zhang","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.02.033_bib0290","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1161\/01.CIR.99.9.1156","article-title":"Demonstration of rapid onset vascular endothelial dysfunction after hyperhomocysteinemia: an effect reversible with vitamin C therapy","volume":"99","author":"Chambers","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.02.033_bib0295","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1182\/blood.V94.3.959.415k20_959_967","article-title":"Homocysteine-induced endoplasmic reticulum stress and growth arrest leads to specific changes in gene expression in human vascular endothelial cells","volume":"94","author":"Outinen","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.02.033_bib0300","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1161\/01.CIR.103.22.2717","article-title":"Homocysteine induces expression and secretion of monocyte chemoattractant protein-1 and interleukin-8 in human aortic endothelial cells: implications for vascular disease","volume":"103","author":"Poddar","year":"2001","journal-title":"Circ"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.02.033_bib0305","doi-asserted-by":"crossref","first-page":"834","DOI":"10.3109\/00207454.2013.879580","article-title":"Different risk factors between intracranial and extracranial atherosclerotic stenosis in Asian population: a systematic review and meta-analysis","volume":"124","author":"Ding","year":"2014","journal-title":"Int J Neurosci"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.02.033_bib0310","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1080\/01616412.2016.1250856","article-title":"Risk factors between intracranial\u2013extracranial atherosclerosis and anterior\u2013posterior circulation stroke in ischaemic stroke","volume":"39","author":"Li","year":"2017","journal-title":"Neurol Res"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.02.033_bib0315","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1212\/01.wnl.0000208404.94585.b2","article-title":"Prospective study of symptomatic atherothrombotic intracranial stenoses. The GESICA Study","volume":"66","author":"Mazighi","year":"2006","journal-title":"Neurol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.02.033_bib0320","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1159\/000323610","article-title":"Clinical and radiological outcomes after intracranial atherosclerotic stroke: a comprehensive approach comparing stroke subtypes","volume":"31","author":"Kim","year":"2011","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.02.033_bib0325","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1161\/STROKEAHA.111.641696","article-title":"Risk factors and outcome of patients with symptomatic intracranial stenosis presenting with lacunar stroke","volume":"43","author":"Khan","year":"2012","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.02.033_bib0330","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1161\/01.STR.29.7.1389","article-title":"Prognosis of patients with symptomatic vertebral or basilar artery stenosis","volume":"29","year":"1998","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.02.033_bib0335","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1105335","article-title":"Stenting versus aggressive medical therapy for intracranial arterial stenosis","volume":"365","author":"Chimowitz","year":"2011","journal-title":"N Engl J Med"}],"container-title":["Journal of Stroke and Cerebrovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1052305718300958?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1052305718300958?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T06:39:51Z","timestamp":1760942391000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1052305718300958"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":66,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S1052305718300958"],"URL":"https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2018.02.033","relation":{},"ISSN":["1052-3057"],"issn-type":[{"value":"1052-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Which Ischemic Stroke Subtype Is Associated with Hyperhomocysteinemia?","name":"articletitle","label":"Article Title"},{"value":"Journal of Stroke and Cerebrovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2018.02.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Inc. on behalf of National Stroke Association.","name":"copyright","label":"Copyright"}]}}